CincyTech USA

03/12/2026

➡️"Meaningful clinical innovation depends not only on discovery, but on the pathway that carries it from lab to market." - Cincinnati Children's Hospital Medical Center Innovation Ventures Team

We couldn't agree more with our partners at Cincinnati Children's Innovation Ventures. Great science is the foundation, but getting that science into the hands of clinicians requires a dedicated commercialization vehicle.

CincyTech is incredibly proud to have been part of the Eyas Medical Imaging journey from its early days. Seeing the Ascent3T™ reach this FDA milestone is a powerful example of how institutional research and startup agility can converge to solve the most complex healthcare challenges.

Read more about Eyas and dive into how children’s hospitals are evolving into high-growth medtech hubs to close a critical gap: 𝐩𝐞𝐝𝐢𝐚𝐭𝐫𝐢𝐜 𝐢𝐧𝐧𝐨𝐯𝐚𝐭𝐢𝐨𝐧 𝐜𝐮𝐫𝐫𝐞𝐧𝐭𝐥𝐲 𝐥𝐚𝐠𝐬 𝐧𝐞𝐚𝐫𝐥𝐲 𝐚 𝐝𝐞𝐜𝐚𝐝𝐞 𝐛𝐞𝐡𝐢𝐧𝐝 𝐚𝐝𝐮𝐥𝐭 𝐝𝐞𝐯𝐢𝐜𝐞𝐬. As the FDA streamlines the path to market, this underserved sector is projected to nearly double, reaching $18.4 billion by 2030, ensuring that clinicians no longer have to "make do" with adult-sized devices for their smallest patients.

Check out the full feature by Lauren Dubinsky in Modern Healthcare at the link in the post below👇

Hospitals, companies and the FDA are finding ways to advance pediatric medical devices in a challenging market.

03/11/2026

What a day at the Alloy Development Co. Annual Celebration of Economic Achievement! 🎉

It was an honor to gather with some of Cincinnati’s brightest leaders to recognize the incredible growth and economic impact happening right here in our backyard.

A huge thank you to Brendon Cull, President of the Cincinnati Regional Chamber, for his insightful remarks on our path forward. His vision for cultivating a thriving ecosystem reinforces why we do what we do: making Cincinnati a premier destination to live, innovate, create, and learn.

We want to extend a massive congratulations to all of today’s award winners!

We are especially proud to see CincyTech portfolio company STACK Construction Technologies recognized. Watching your team scale and redefine your industry is a testament to the talent we have in this city.

To all the winners and finalists: each of you is a crucial part of what makes Cincinnati such a powerhouse to be.

Let’s keep building and scaling. 📈

|

02/28/2026

To most, Cystic Fibrosis is a medical statistic. To Amanda and Andrew Jamison, it’s the daily reality of their daughter, Finley.

Finley is pure joy. She’s sassy, she’s a gymnast, and she’s the funniest toddler in the room. But behind the smiles is a "daily reality" that never takes a day off:

⏩ Over 40 pills every single day.

⏩ A feeding pump that runs while she sleeps to support her growth.

⏩ Hours of airway clearance and nebulizer treatments to protect her lungs.

⏩ Up to 6 medical appointments every week.

"I’ll never let it steal her joy or define her childhood," Amanda, Finley’s mom, says. But as she and Andrew know all too well, while breakthroughs like modulators have been life-changing, they are not yet a cure.

This is why CincyTech exists. Our mission is to transform high-potential ideas—across technology and life sciences—into world-class companies. We fund the complex technologies that bridge the gap between a laboratory breakthrough and a child’s life.

We are proud to back Clarametyx Biosciences, a company attacking the challenges that persist for the 1 in 10 Americans living with a rare disease.

Clarametyx is developing CMTX-101, a "biofilm-disrupting" technology that targets the protective shield bacteria use to hide in the lungs.

By funding this science, we aim to help strip away those barriers, giving people like Finley and her parents the hope of better breathing for more time.

𝐓𝐨𝐝𝐚𝐲 𝐢𝐬 𝐑𝐚𝐫𝐞 𝐃𝐢𝐬𝐞𝐚𝐬𝐞 𝐃𝐚𝐲.

With more than 95% of rare diseases still lacking an FDA-approved treatment, the urgency for innovation has never been greater.

We invite you to with us to help spread awareness for the 30 million Americans living with a rare disease.

We fund the science so Finley can focus on being a kid.

How are you showing your stripes today?

02/25/2026

The energy at this morning’s "Welcome to the Ecosystem" event was incredible. Huge thanks to Cintrifuse for hosting such a high-impact gathering and bringing the community together.

​Ashley, Logan, and Will had a fantastic time connecting with everyone. We met students just beginning to explore the world of tech, seasoned founders, and key players navigating every stage of the innovation journey.

​The talent and grit in this room is what makes our community so strong, and we left today feeling inspired. Whether you're building, investing, or just curious about what’s next, we’re glad you’re here.

​Let’s keep the momentum going! 🔥

02/19/2026

Big wins for the 513! 💥

Huge congratulations to our portfolio company, Losant, on their acquisition by SUSE!

From early-stage startup to a global Industrial IoT leader, we’ve loved being part of the journey.

Why is this a game-changer?

It’s all about the "Tiny Edge." 🌐

While most IoT solutions stop at the gateway, Losant reaches directly into sensors and machines where the physical world meets the digital. By joining forces with SUSE, they are creating the world’s first full-stack, open-source automation platform.

What this means for the industry:

🔹 Bridging OT & IT: Seamlessly connecting factory-floor hardware with enterprise-level AI.

🔹 Open Source Economics: Breaking vendor lock-in so companies can innovate faster and more affordably.

🔹 Real-Time Intelligence: Decisions happen in milliseconds directly on the device.

This move isn't just a win for Losant; it’s a massive proof point for the talent and innovation coming out of Cincinnati. 📈🚀

Read more here: https://www.suse.com/news/suse-acquires-losant/

02/06/2026

New to the scene? 🔌✨

If you’re new to Cincinnati or just starting your journey into the innovation world, Welcome to the Ecosystem is your "where-to-start" guide.

We’re taking over a table at Union Hall on Feb 25th to help you cut through the noise. Come find out how to get involved, meet the community, and learn how CincyTech helps local founders grow.

Where to find us:
🗓 Wednesday, Feb 25th
⏰ 10am - 12pm
📍 Union Hall (Beer Hall)
🔗 Register here: https://luma.com/zht10jt0

Will we see you there? 👀

StartupCincy

02/05/2026

We are thrilled to share that CincyTech portfolio company Eyas Medical Imaging has officially received FDA 510(k) clearance for its Ascent3T™ Neonatal MRI System.

This is a game-changer for neonatal care. The Ascent3T is the world's first high-field, 3 Tesla MRI system designed specifically for the smallest and most vulnerable patients.

Why this matters:

✨ Point-of-Care Imaging: Its compact, virtually helium-free design allows it to be installed directly inside the NICU.

✨ Reduced Risk: Eliminates the need to transport fragile newborns through hospital hallways to imaging suites.

✨ Unmatched Precision: Provides high-resolution 3T imaging of the brain, lungs, heart, and abdomen, tailored specifically to infant anatomy.

Born out of world-class research at Cincinnati Children's, Eyas is a prime example of how local innovation is solving global healthcare challenges.

Congratulations to Matt Storer, Dr. Charles Dumoulin, and the entire Eyas team on this incredible achievement.

Read the full announcement here:

Eyas Medical Imaging, Inc. has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its Ascent3T™ Neonatal Magnetic Resonance Imaging (MRI) ...

02/04/2026

A Powerful Milestone for Ohio Innovation 🚀🌰

We are incredibly proud to celebrate a major milestone for one of our portfolio companies, Genetesis. After 12 years of pioneering magnetocardiography technology in the City of Mason, Ohio, the company has officially exited following the sale of its business assets to a multibillion-dollar technology leader.

While we celebrate this successful acquisition, we are equally thrilled to congratulate Peeyush Shrivastava on his next chapter as a Principal at The O.H.I.O. Fund. In a wonderful full-circle moment, Peeyush will be working alongside our former CEO, Mike Venerable, to lead the charge in funneling more investment and support into the Greater Cincinnati area.

This isn’t just a win for Genetesis; it’s a win for Ohio. A global player recognizing the value of technology developed right here in our backyard proves our region competes at the highest level. Perhaps even more importantly, we are retaining the visionary talent that built this success

Peeyush joining the O.H.I.O. Fund is a prime example of a thriving ecosystem in action ➡️ where the expertise gained over a decade of building is recycled back into the community to drive the next wave of innovation.

Peeyush, it has been a privilege to support you from the early days. Thank you for your dedication to the Mason tech community over the last 12 years. We are honored to have been part of your journey and can’t wait to see the impact you’ll continue to make for Ohio entrepreneurs!

To read the full Cincinnati Business Courier Cincy Inno article👉

Startup backed by Mark Cuban, CincyTech exits >> See the full article below ⬇️

01/23/2026

Earlier this month, the CincyTech team had the chance to take over the 🧠Learning Lab at the University of Cincinnati's 1819 Innovation Hub to dive deep into the principles of Jim Collins’ book, "Good to Great."

We didn't just talk theory; we got to work.

In high-growth environments, complexity is the default, but focus beats complexity. We spent the day identifying our "One Big Thing," the core mission that allows us to say no to distractions so we can say yes to impact.

Our Key Takeaways:

➡️ Alignment Multiplies Energy: When our team is aligned on our mission and vision, every ounce of effort is amplified.

➡️ The Flywheel Effect: Momentum is earned. You don't lose momentum if you don't stop pushing; you just have to keep the right pressure on the right points.

➡️ Friction is Feedback: We’re leaning into the challenges, using them as data points to refine our process.

➡️ The Intersection of Success: True momentum follows when passion, excellence, and our economic engine meet.

The work doesn't end when we leave the 1819 Hub. We’re already back at it, with follow-up sessions on the calendar to keep narrowing our focus. By staying disciplined about what we do best, we’re ensuring every member of our team feels the pride and purpose that come with true alignment.

A huge thank you to the team at the 1819 Innovation Hub and Learning Lab for hosting us and facilitating such a productive environment. Specifically, thank you to Nicholas Partridge, Kurt Myers, and Rebecca Rudolph for your guidance and support in making this session happen.

Greatness is a process of discipline, and we’re just getting started. 📈🔥

01/23/2026

Huge congratulations to Aaron Chow and Anu Vora for being named to the OhioX Next25!

This list recognizes the individuals shaping what’s next for our state’s tech ecosystem. We were honored to submit their nominations and are thrilled to see their hard work recognized:

✨Aaron Chow, Founder & CEO of our portfolio company, Vixiv, continues to push the boundaries of what’s possible within our portfolio.

✨Anu Vora is a dedicated leader whose contributions are making a lasting mark on the tech landscape in Ohio and beyond.

The energy and innovation these two bring to the table are exactly what drive our ecosystem forward. Well deserved!

Meet all of Ohio's Next25: https://www.ohiotechnews.com/meet-next25-2025/

01/20/2026

JPM 2026 🌉 marked a fundamental shift for the biotech sector: a move away from speculative "storyline" hype toward tangible, data-driven validation.

Our Life Sciences Partner, Kenny Morand, is back from San Francisco with strategic insights on what this "new reality" means for the year ahead.

From landmark FDA pivots to the latest IPO "litmus tests," Kenny breaks down the critical quiet wins that will define 2026.

Key Takeaways:

♦️FDA Flexibility: A major shift in 21 CFR part 211 standards that will decrease clinical trial costs and increase speed.

♦️AI as Infrastructure: The $1B Lilly-Nvidia deal proves AI has moved beyond the buzzword phase into a core drug discovery backbone.

♦️The New "Lean and Mean": 2026 winners are focused on high-value therapeutic assets and measurable results.

Read Kenny's full analysis here 👉 https://cincytechusa.com/news/jpm-2026-the-shift-from-survival-to-cautious-optimism

01/20/2026

Big moves at CincyTech! 🚀

We are thrilled to announce that Sean Kwiat has been promoted to Vice President, Investments!

Since joining the team in 2015, Sean has been a driving force behind our investment strategy, contributing to over 100 early-stage financings and providing the financial acumen that helps our portfolio companies thrive.

In this new leadership role, Sean will head our investment team, driving deal flow and building a portfolio focused on high-impact technology and life sciences. Beyond capital allocation, he mentors our team of analysts and associates and plays a pivotal role in fund management. Sean will continue to be a dedicated partner to our founders, guiding them through early operational hurdles to secure follow-on institutional capital and achieve successful exits.

🎉Please join us in congratulating Sean on this well-deserved milestone! We can’t wait to see the impact he continues to make as we transform regional ideas into world-class companies.